Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.3%

1 terminated out of 23 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

13%

3 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (13)
P 2 (1)
P 3 (2)
P 4 (1)

Trial Status

Completed11
Recruiting6
Unknown4
Not Yet Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07572422Not ApplicableCompleted

Use of Various Types of Introducers in Conventional Radial Access

NCT03630055Phase 3TerminatedPrimary

Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion

NCT07380399RecruitingPrimary

Transulnar Access in Patients With Ipsilateral Radial Artery Occlusion Undergoing Coronary Angiography or Angioplasty

NCT06981624Not ApplicableRecruitingPrimary

Comparison of the Systematic Versus the Selective Use of Heparin for the Prevention of Radial Artery Occlusion

NCT06787287Not ApplicableCompleted

A Study on the Application of Simple and Improved Radial Artery Compression Method After Transradial Coronary Intervention

NCT06890312Not ApplicableRecruiting

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

NCT07087522Not ApplicableNot Yet Recruiting

Impact of Preprocedural Stress Ball Use on Radial Artery Outcomes in Elective Coronary Angiography

NCT04933136RecruitingPrimary

Radial Artery Occlusion and Dual Artery Hemostasis After Transradial Approach.

NCT06812455Phase 4RecruitingPrimary

Effect of RIVAroxaban in Radial Artery Occlusion Treatment After Cardiac Catheterization

NCT06293287Phase 2UnknownPrimary

Enoxaparin for Preventing the Radical Artery Occlusion After the Transradial Access Hepatic Arterial Infusion Chemotherapy

NCT04561648Not ApplicableRecruitingPrimary

Standard vs High Dose of Unfractionated Heparin in the Incidence of Radial Artery Occlusion (DEFINITION) Trial.

NCT05253820Not ApplicableCompleted

Long-term Radial Artery Occlusion in Coronary Diagnosis and Intervention Via Distal Radial Approach (CONDITION)

NCT05591872Phase 3UnknownPrimary

Low Dose Heparin Factorial Trial

NCT04380883Not ApplicableCompletedPrimary

Combination of InnoSEAL Plus TR Band Compared to TR Band Alone

NCT04911218Not ApplicableCompleted

GlideSheath Slender® Versus Conventional 5Fr Arterial Sheath in Coronary Angiography Through the Distal Radial Artery

NCT04861389Not ApplicableUnknown

Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients

NCT03789279CompletedPrimary

Observational Study of Hand Function After Distal Transradial Access for Angiography

NCT04748068Not ApplicableUnknownPrimary

Use of Glidesheath Slender to Reduce Radial Artery Occlusion Following 7 French Transradial Coronary Intervention

NCT04238026Not ApplicableCompletedPrimary

Distal Radial Artery Approach to Prevent Radial Artery Occlusion (DAPRAO)

NCT03298126Not ApplicableCompletedPrimary

Is Conventional TR Band Deflation Protocol Inferior to Internationally Developed TR Band Removal Protocol in Reducing Occurrence of Radial Artery Occlusion

Scroll to load more

Research Network

Activity Timeline